{"id":4085,"date":"2026-07-28T22:48:50","date_gmt":"2026-07-28T19:48:50","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4085"},"modified":"2026-07-28T22:48:52","modified_gmt":"2026-07-28T19:48:52","slug":"mutations-amenable-to-exon-50-skipping","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/mutations-amenable-to-exon-50-skipping\/","title":{"rendered":"Duchenne Musk\u00fcler Distrofisi'nde Ekzon 50 Atlama Terapilerine Uygun Delesyonlar"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Ekzon 50 atlamaya uygun delesyonlar (silinmeler), Duchenne kas distrofisi (DMD) ara\u015ft\u0131rmalar\u0131nda \u00f6nemli bir konudur \u00e7\u00fcnk\u00fc ekzon atlama terapileri, belirli genetik mutasyonlara sahip hastalarda DMD geninin bozulmu\u015f okuma \u00e7er\u00e7evesini onarmak i\u00e7in tasarlanm\u0131\u015ft\u0131r.<\/strong> Ayn\u0131 rahats\u0131zl\u0131\u011fa sahip t\u00fcm bireyleri hedef alan geleneksel tedavilerin aksine, ekzon atlama, yaln\u0131zca belirli mutasyon modellerine sahip hastalara fayda sa\u011flayan bir hassas t\u0131p y\u00f6ntemidir. Ekzon 50 atlamaya uygun mutasyonlar\u0131 anlamak, ailelerin genetik test sonu\u00e7lar\u0131n\u0131 daha iyi yorumlamalar\u0131na, ortaya \u00e7\u0131kan klinik \u00e7al\u0131\u015fmalar\u0131 takip etmelerine ve n\u00f6rom\u00fcsk\u00fcler uzmanlar\u0131yla gelecekteki tedavi se\u00e7eneklerini g\u00f6r\u00fc\u015fmelerine yard\u0131mc\u0131 olur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMD geni 79 ekzon i\u00e7erir ve kas liflerini hasardan koruyan yap\u0131sal bir protein olan distrofinin \u00fcretimi i\u00e7in talimatlar sa\u011flar. Silinmeler veya di\u011fer mutasyonlar okuma \u00e7er\u00e7evesini bozdu\u011funda, distrofin \u00fcretimi ciddi \u015fekilde azal\u0131r veya tamamen durur ve bu da ilerleyici kas g\u00fc\u00e7s\u00fczl\u00fc\u011f\u00fcne yol a\u00e7ar. Ekzon atlama terapileri, h\u00fccreleri RNA ekleme s\u0131ras\u0131nda se\u00e7ilen ekzonlar\u0131 atlamaya te\u015fvik etmek i\u00e7in antisens oligon\u00fckleotidler (ASO&#039;lar) kullan\u0131r ve potansiyel olarak Becker kas distrofisinde g\u00f6r\u00fclenlere benzer daha k\u0131sa ancak i\u015flevsel bir distrofin proteininin \u00fcretimini geri kazand\u0131r\u0131r. Daha Fazla Bilgi Edinin: <a href=\"https:\/\/dmdwarrior.com\/tr\/dystrophin-gene\/\" target=\"_blank\" rel=\"noreferrer noopener\">Distrofin Geni<\/a><\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#mutations-amenable-to-exon-50-skipping\">Ekzon 50 Atlamaya Uygun Mutasyonlar<\/a><\/li><li><a href=\"#how-does-exon-50-skipping-work\">Ekzon 50 Atlama Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/a><\/li><li><a href=\"#why-are-only-certain-patients-eligible\">Neden sadece belirli hastalar bu tedaviden yararlanabiliyor?<\/a><ul><li><a href=\"#who-can-benefit-from-exon-50-skipping\">Ekzon 50 atlama tedavilerinden kimler faydalanabilir?<\/a><\/li><\/ul><\/li><li><a href=\"#current-research-on-exon-50-skipping-therapy\">Ekzon 50 Atlama Terapisi \u00dczerine G\u00fcncel Ara\u015ft\u0131rmalar<\/a><ul><li><a href=\"#improved-antisense-oligonucleotides\">Geli\u015ftirilmi\u015f Antisens Oligon\u00fckleotidler<\/a><\/li><li><a href=\"#enhanced-delivery-systems\">Geli\u015ftirilmi\u015f Teslimat Sistemleri<\/a><\/li><li><a href=\"#better-dystrophin-expression\">Daha \u0130yi Distrofin \u0130fadesi<\/a><\/li><li><a href=\"#combination-therapies\">Kombinasyon Terapileri<\/a><\/li><\/ul><\/li><li><a href=\"#frequently-asked-questions\">S\u0131k\u00e7a Sorulan Sorular<\/a><ul><li><a href=\"#faq-question-1785266038331\">Ekzon 50 atlama terapisi kesin sonu\u00e7 verir mi?<\/a><\/li><li><a href=\"#faq-question-1785266050896\">Her hastaya ekzon 50 atlama tedavisi uygulanabilir mi?<\/a><\/li><li><a href=\"#faq-question-1785266059963\">Aileler Uygun Olup Olmad\u0131klar\u0131n\u0131 Nas\u0131l \u00d6\u011frenebilirler?<\/a><\/li><li><a href=\"#faq-question-1785266067988\">Klinik ara\u015ft\u0131rmalar mevcut mu?<\/a><\/li><\/ul><\/li><li><a href=\"#future-outlook\">Gelecek G\u00f6r\u00fcn\u00fcm\u00fc<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"mutations-amenable-to-exon-50-skipping\" class=\"wp-block-heading\">Ekzon 50 Atlamaya Uygun Mutasyonlar<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 50 atlamaya uygun delesyonlar, ekzon 50'nin atlanmas\u0131n\u0131n bozulmu\u015f okuma \u00e7er\u00e7evesini onarabilece\u011fi ve k\u0131smen i\u015flevsel distrofin \u00fcretimini sa\u011flayabilece\u011fi genetik varyantlar\u0131 ifade eder. <strong>Yay\u0131nlanm\u0131\u015f mutasyon uygulanabilirlik analizlerine dayanarak, ekzon 50 atlamas\u0131, 8-49, 20-49, 22-49, 51, 51-53, 51-55, 51-57, 51-59, 51-60, 51-67, 51-69, 51-75 veya 51-78 dahil olmak \u00fczere belirli delesyon modelleri i\u00e7in ara\u015ft\u0131r\u0131lm\u0131\u015ft\u0131r.<\/strong> Bu delesyon modelleri, teorik olarak 50. ekzon atlamas\u0131n\u0131n okuma \u00e7er\u00e7evesini geri kazand\u0131rabilece\u011fi mutasyon \u00f6rnekleridir. Bununla birlikte, tedavi kararlar\u0131 yaln\u0131zca ekzon say\u0131lar\u0131na dayanarak verilemeyece\u011finden, her hastan\u0131n uygunlu\u011fu her zaman kapsaml\u0131 genetik testler, okuma \u00e7er\u00e7evesi analizi ve deneyimli bir n\u00f6rom\u00fcsk\u00fcler uzman\u0131yla g\u00f6r\u00fc\u015fme yoluyla do\u011frulanmal\u0131d\u0131r. Daha Fazla Bilgi Edinin: <a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-exon-deletion-in-duchenne-muscular-dystrophy-dmd\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ekzon Delesyonu Nedir?<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"864\" height=\"1821\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr.png\" alt=\"Duchenne kas distrofisinde ekzon 50 atlamaya uygun delesyonlar (silinmeler) (infografik)\" class=\"wp-image-8303\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr.png 864w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-142x300.png 142w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-486x1024.png 486w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-768x1619.png 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-729x1536.png 729w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-6x12.png 6w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-199x420.png 199w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-150x316.png 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-300x632.png 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/07\/mutations-amenable-to-exon-50-skipping-infographic-tr-696x1467.png 696w\" sizes=\"(max-width: 864px) 100vw, 864px\" \/><figcaption class=\"wp-element-caption\">Bu infografik, Duchenne kas distrofisinde ekzon 50 atlamas\u0131na uygun mutasyonlar olarak \u015fu anda kabul edilen ekzon delesyon modellerini \u00f6zetlemektedir.<\/figcaption><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"how-does-exon-50-skipping-work\" class=\"wp-block-heading\">Ekzon 50 Atlama Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon atlama terapisi, DNA yerine haberci RNA'y\u0131 (mRNA) hedef al\u0131r. DMD geni RNA'ya d\u00f6n\u00fc\u015ft\u00fcr\u00fcld\u00fckten sonra, antisens oligon\u00fckleotidler ekzon 50 \u00e7evresindeki belirli dizilere ba\u011flanarak, h\u00fccresel ekleme mekanizmas\u0131n\u0131n RNA i\u015fleme s\u0131ras\u0131nda bu ekzonu d\u0131\u015flamas\u0131na neden olur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tedavinin amac\u0131 \u015fudur:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hasar g\u00f6rm\u00fc\u015f okuma \u00e7er\u00e7evesini onarmak<\/li>\n\n\n\n<li>\u0130\u00e7ten k\u0131salt\u0131lm\u0131\u015f distrofin proteini \u00fcretmek<\/li>\n\n\n\n<li>Kas y\u0131k\u0131m\u0131n\u0131 yava\u015flatmak<\/li>\n\n\n\n<li>Kas g\u00fcc\u00fcn\u00fc ve fonksiyonunu korumak<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">CRISPR gibi gen d\u00fczenleme teknolojilerinin aksine, ekzon atlama DNA'y\u0131 kal\u0131c\u0131 olarak de\u011fi\u015ftirmez. Bunun yerine, RNA'n\u0131n i\u015flenme \u015feklini ge\u00e7ici olarak de\u011fi\u015ftirir; bu da genellikle tekrarlanan tedavi gerektirdi\u011fi anlam\u0131na gelir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"why-are-only-certain-patients-eligible\" class=\"wp-block-heading\">Neden sadece belirli hastalar bu tedaviden yararlanabiliyor?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ailelerin en s\u0131k sordu\u011fu sorulardan biri \u015fudur:<\/p>\n\n\n\n<h3 id=\"who-can-benefit-from-exon-50-skipping\" class=\"wp-block-heading\">Ekzon 50 atlama tedavilerinden kimler faydalanabilir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Yaln\u0131zca mutasyonlar\u0131 ekzon 50 atlamas\u0131yla uyumlu olan bireyler potansiyel aday olarak de\u011ferlendirilir.<\/strong> Her DMD mutasyonu okuma \u00e7er\u00e7evesini farkl\u0131 \u015fekilde etkiledi\u011finden, ayn\u0131 tedavi her hasta i\u00e7in kullan\u0131lamaz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Uygunluk \u00e7e\u015fitli fakt\u00f6rlere ba\u011fl\u0131d\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tam ekzon silme paterni<\/li>\n\n\n\n<li>Okuma \u00e7er\u00e7evesi bozulmas\u0131<\/li>\n\n\n\n<li>Molek\u00fcler tan\u0131 bulgular\u0131<\/li>\n\n\n\n<li>Klinik \u00e7al\u0131\u015fma dahil etme kriterleri<\/li>\n\n\n\n<li>D\u00fczenleyici onay durumu<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Sertifikal\u0131 bir genetik laboratuvar, hastan\u0131n mutasyonunun teorik olarak ekzon 50 atlamas\u0131na uygun olup olmad\u0131\u011f\u0131n\u0131 belirleyebilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"current-research-on-exon-50-skipping-therapy\" class=\"wp-block-heading\">Ekzon 50 Atlama Terapisi \u00dczerine G\u00fcncel Ara\u015ft\u0131rmalar<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u015eu anda onaylanm\u0131\u015f ekzon atlama terapileri baz\u0131 b\u00f6lgelerde 45, 51 ve 53 gibi ekzonlar\u0131 hedef alsa da, ara\u015ft\u0131rmac\u0131lar 50. ekzon da dahil olmak \u00fczere ek ekzonlar i\u00e7in terapiler \u00fczerinde \u00e7al\u0131\u015fmalar\u0131na devam etmektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">G\u00fcncel ara\u015ft\u0131rma alanlar\u0131 \u015funlard\u0131r:<\/p>\n\n\n\n<h3 id=\"improved-antisense-oligonucleotides\" class=\"wp-block-heading\">Geli\u015ftirilmi\u015f Antisens Oligon\u00fckleotidler<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bilim insanlar\u0131, kas dokusuna daha fazla n\u00fcfuz eden ve daha kararl\u0131 ASO&#039;lar geli\u015ftiriyorlar.<\/p>\n\n\n\n<h3 id=\"enhanced-delivery-systems\" class=\"wp-block-heading\">Geli\u015ftirilmi\u015f Teslimat Sistemleri<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Yeni peptit konjugeli oligon\u00fckleotidler, iskelet kas\u0131na, diyaframa ve kalp kas\u0131na ila\u00e7 iletimini iyile\u015ftirmeyi ama\u00e7lamaktad\u0131r.<\/p>\n\n\n\n<h3 id=\"better-dystrophin-expression\" class=\"wp-block-heading\">Daha \u0130yi Distrofin \u0130fadesi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ara\u015ft\u0131rmac\u0131lar, yeni kimyasallar\u0131n g\u00fcvenli\u011fi korurken distrofin \u00fcretimini art\u0131r\u0131p art\u0131ramayaca\u011f\u0131n\u0131 de\u011ferlendiriyor.<\/p>\n\n\n\n<h3 id=\"combination-therapies\" class=\"wp-block-heading\">Kombinasyon Terapileri<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Gelecekteki tedavi stratejileri, ekzon atlama y\u00f6ntemini gen terapisi, gen d\u00fczenleme, anti-enflamatuar ila\u00e7lar veya kas koruyucu tedavilerle birle\u015ftirebilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"frequently-asked-questions\" class=\"wp-block-heading\">S\u0131k\u00e7a Sorulan Sorular<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list\">\n<div id=\"faq-question-1785266038331\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Ekzon 50 atlama terapisi kesin sonu\u00e7 verir mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Hay\u0131r. Ekzon atlama, Duchenne kas distrofisini kal\u0131c\u0131 olarak tedavi etmekten ziyade distrofin \u00fcretimini iyile\u015ftirmeyi ama\u00e7layan, hastal\u0131\u011f\u0131 de\u011fi\u015ftiren bir tedavi olarak kabul edilir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1785266050896\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Her hastaya ekzon 50 atlama tedavisi uygulanabilir mi?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Hay\u0131r. Sadece ekzon 50 atlamas\u0131na uygun mutasyonlara sahip hastalar, ayr\u0131nt\u0131l\u0131 genetik de\u011ferlendirme sonras\u0131nda potansiyel olarak fayda g\u00f6rebilirler. <strong>\u015eimdi Ke\u015ffedin<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/duchenne-exon-deletion-tool\/\" target=\"_blank\" rel=\"noreferrer noopener\">DMDWarrioR Exon Kontrol Arac\u0131<\/a><\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1785266059963\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Aileler Uygun Olup Olmad\u0131klar\u0131n\u0131 Nas\u0131l \u00d6\u011frenebilirler?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Uygunluk, hastan\u0131n t\u00fcm genetik raporunun bir n\u00f6rom\u00fcsk\u00fcler uzman\u0131 veya genetik dan\u0131\u015fman ile birlikte incelenmesiyle belirlenmelidir.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-question-1785266067988\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question\">Klinik ara\u015ft\u0131rmalar mevcut mu?<\/h3>\n<div class=\"rank-math-answer\">\n\n<p>Yeni ekzon atlama terapilerini ara\u015ft\u0131rmak i\u00e7in klinik \u00e7al\u0131\u015fmalar devam etmektedir. Aileler d\u00fczenli olarak ClinicalTrials.gov&#039;yi g\u00f6zden ge\u00e7irmeli ve sa\u011fl\u0131k ekibiyle klinik \u00e7al\u0131\u015fma f\u0131rsatlar\u0131n\u0131 g\u00f6r\u00fc\u015fmelidir. <strong>\u015eimdi Ke\u015ffedin<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/clinical-trials\/\" target=\"_blank\" rel=\"noreferrer noopener\">DMDWarrioR Klinik Ara\u015ft\u0131rmalar Merkezi<\/a><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"future-outlook\" class=\"wp-block-heading\">Gelecek G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne kas distrofisi i\u00e7in hassas t\u0131p alan\u0131n\u0131n gelece\u011fi h\u0131zla geli\u015fiyor. Ekzon atlama, gen replasman tedavisi, CRISPR tabanl\u0131 gen d\u00fczenleme, RNA terapileri ve yeni ila\u00e7 uygulama teknolojilerindeki geli\u015fmeler, mutasyona \u00f6zg\u00fc tedavi stratejilerinin yelpazesini geni\u015fletiyor. Ara\u015ft\u0131rmac\u0131lar DMD geni ve distrofin biyolojisi hakk\u0131nda daha iyi bir anlay\u0131\u015fa sahip olduk\u00e7a, daha fazla hasta ki\u015fiselle\u015ftirilmi\u015f tedaviler i\u00e7in uygun hale gelebilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aileler i\u00e7in, sayg\u0131n bilimsel kurulu\u015flar, hakemli yay\u0131nlar ve deneyimli n\u00f6rom\u00fcsk\u00fcler uzmanlar arac\u0131l\u0131\u011f\u0131yla bilgi sahibi olmak, gelecekteki tedavi f\u0131rsatlar\u0131na haz\u0131rlanman\u0131n en iyi yoludur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Daha fazla bilgi edin: <a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">ClinicalTrials.gov<\/a>. Devam eden Duchenne kas distrofisi klinik \u00e7al\u0131\u015fmalar\u0131.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Mutations amenable to exon 50 skipping are an important topic in Duchenne muscular dystrophy (DMD) research because exon skipping therapies are designed to restore the disrupted reading frame of the DMD gene in patients with specific genetic mutations. Unlike conventional treatments that target all individuals with the same condition, exon skipping is a form of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8302,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[278,279,475,280,77,178],"class_list":["post-4085","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dmd","tag-exon-50","tag-exon-50-skipping","tag-exon-50-skipping-therapy","tag-exon-50-skipping-treatment","tag-exon-skipping","tag-exon-skipping-therapies"],"subtitle":"Ekzon 50 atlamaya uygun delesyonlar (silinmeler), Duchenne kas distrofisinde ki\u015fiselle\u015ftirilmi\u015f tedavi i\u00e7in yeni olanaklar a\u00e7abilir. Hangi genetik mutasyonlar\u0131n uygun olabilece\u011fini, ekzon 50 atlama tedavilerinin nas\u0131l \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 ve uygunlu\u011fun belirlenmesi ve gelecekteki klinik \u00e7al\u0131\u015fma f\u0131rsatlar\u0131 i\u00e7in do\u011fru genetik testin neden gerekli oldu\u011funu \u00f6\u011frenin.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=4085"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4085\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/8302"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=4085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=4085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=4085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}